Spots Global Cancer Trial Database for dapagliflozin
Every month we try and update this database with for dapagliflozin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Neoadjuvant SGLT2 Inhibition in High-Risk Localized Prostate Cancer | NCT04887935 | Prostate Cancer Cancer of Prost... | Dapagliflozin BIOSENSE Meter | 18 Years - | Washington University School of Medicine | |
| Dapagliflozin Efficacy and Action in PCOS | NCT04213677 | Polycystic Ovar... | Dapagliflozin Placebo | 18 Years - 45 Years | Nanfang Hospital, Southern Medical University | |
| Targeting Pediatric Brain Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) | NCT05521984 | Pediatric Brain... | Dapagliflozin Carmustine | 6 Years - 21 Years | Washington University School of Medicine | |
| DapagliFLOzin in Renal AL Amyloidosis (FLORAL) | NCT06420167 | Renal AL Amyloi... | Dapagliflozin | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition | NCT04542291 | Pancreas Cancer Pancreatic Canc... Cancer of the P... | Dapagliflozin BIOSENSE meters | 18 Years - | Washington University School of Medicine | |
| Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant | NCT04899349 | Breast Cancer | Alpelisib Fulvestrant Metformin XR Dapagliflozin +... Dapagliflozin | 18 Years - | Novartis | |
| DapagliFLOzin in Renal AL Amyloidosis (FLORAL) | NCT06420167 | Renal AL Amyloi... | Dapagliflozin | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition | NCT04542291 | Pancreas Cancer Pancreatic Canc... Cancer of the P... | Dapagliflozin BIOSENSE meters | 18 Years - | Washington University School of Medicine | |
| Neoadjuvant SGLT2 Inhibition in High-Risk Localized Prostate Cancer | NCT04887935 | Prostate Cancer Cancer of Prost... | Dapagliflozin BIOSENSE Meter | 18 Years - | Washington University School of Medicine | |
| Dapagliflozin Efficacy and Action in PCOS | NCT04213677 | Polycystic Ovar... | Dapagliflozin Placebo | 18 Years - 45 Years | Nanfang Hospital, Southern Medical University | |
| DapagliFLOzin in Renal AL Amyloidosis (FLORAL) | NCT06420167 | Renal AL Amyloi... | Dapagliflozin | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity | NCT06341842 | Breast Cancer | Dapagliflozin 1... | 18 Years - 70 Years | Fondazione IRCCS Policlinico San Matteo di Pavia | |
| Targeting Pediatric Brain Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) | NCT05521984 | Pediatric Brain... | Dapagliflozin Carmustine | 6 Years - 21 Years | Washington University School of Medicine | |
| CardioPROTECTion With Dapagliflozin in Breast Cancer Patients Treated With AnthrAcycline - PROTECTAA TRIAL | NCT06304857 | Breast Cancer Heart Failure | Dapagliflozin Placebo | 18 Years - 80 Years | 4th Military Clinical Hospital with Polyclinic, Poland | |
| Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity | NCT06341842 | Breast Cancer | Dapagliflozin 1... | 18 Years - 70 Years | Fondazione IRCCS Policlinico San Matteo di Pavia | |
| Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant | NCT04899349 | Breast Cancer | Alpelisib Fulvestrant Metformin XR Dapagliflozin +... Dapagliflozin | 18 Years - | Novartis |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
